{"data":{"id":3359,"citation":"Shouksmith AE, Gawel JM, Nawar N, Sina D, Raouf YS, Bukhari S, He L, Johns AE, Manaswiyoungkul P, Olaoye OO, Cabral AD, Sedighi A, de Araujo ED, Gunning PT.: Class I\/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia. ACS Med Chem Lett, Volume 11 (1), 2020","title":"Class I\/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia.","doi":"10.1021\/acsmedchemlett.9b00471","doi_url":"https:\/\/doi.org\/10.1021\/acsmedchemlett.9b00471","pmid":"31938464","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31938464\/","year":2020,"journal":"ACS Med Chem Lett","volume":"11","issue":"1","page":"56-64","authors":[{"first_name":"Bukhari S","last_name":null,"full_name":null},{"first_name":"Cabral AD","last_name":null,"full_name":null},{"first_name":"de Araujo ED","last_name":null,"full_name":null},{"first_name":"Gawel JM","last_name":null,"full_name":null},{"first_name":"Gunning PT.","last_name":null,"full_name":null},{"first_name":"He L","last_name":null,"full_name":null},{"first_name":"Johns AE","last_name":null,"full_name":null},{"first_name":"Manaswiyoungkul P","last_name":null,"full_name":null},{"first_name":"Nawar N","last_name":null,"full_name":null},{"first_name":"Olaoye OO","last_name":null,"full_name":null},{"first_name":"Raouf YS","last_name":null,"full_name":null},{"first_name":"Sedighi A","last_name":null,"full_name":null},{"first_name":"Shouksmith AE","last_name":null,"full_name":null},{"first_name":"Sina D","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/3359","landing_page":"https:\/\/molmedb.upol.cz\/publication\/3359","created_at":"2024-05-21T20:11:50.000000Z","updated_at":null}}